CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 136 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 900 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 900 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 900 | -52.6% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 1,900 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -64.3% | 1,900 | -60.5% | 0.00% | -100.0% |
| Q3 2017 | $14,000 | +16.7% | 4,815 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $12,000 | -29.4% | 4,815 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $17,000 | +21.4% | 4,815 | +18.0% | 0.00% | 0.0% |
| Q4 2016 | $14,000 | -12.5% | 4,081 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $16,000 | -11.1% | 4,081 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $18,000 | +80.0% | 4,081 | +551.9% | 0.00% | 0.0% |
| Q4 2015 | $10,000 | – | 626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |